Association between self-administrated prophylactics and SARS-CoV-2 infection among traditional market vendors from the Central Highlands of Peru: A nested case-control study.

Publication date: Jul 11, 2025

Although COVID-19 is no longer a public health emergency of international concern, understanding behaviours such as self-medication remains relevant for informing future outbreak responses and improving public health preparedness. Despite its widespread use during the pandemic, research on medications preventing SARS-CoV-2 infection in healthy individuals is scarce. We investigated the association between self-administered prophylactics and SARS-CoV-2 infection during the third wave of the pandemic in Peru. A nested case-control study was carried out in a cohort of traditional market vendors in the Peruvian Central Highlands, enrolled in a health program. Cases (positive SARS-CoV-2 diagnosis) were matched with controls (negative) by age, sex, and market of origin. Conditional logistic regression models were fitted to evaluate the association between self-administered prophylactics and SARS-CoV-2 infection. As a result, 73 cases were matched with 176 controls. Acetylsalicylic acid consumption increased SARS-CoV-2 infection odds (adjusted Odds Ratio 2. 34; 95% Confidence Interval 1. 17-4. 66). Conversely, vitamin C consumption reduced infection odds (adjusted Odds Ratio 0. 44; 95% Confidence Interval 0. 23-0. 87). Finally, not having the COVID-19 booster increased infection odds (adjusted Odds Ratio 3. 38; 95% Confidence Interval 1. 43-7. 95). In conclusion, our findings suggest that acetylsalicylic acid consumption increased the odds of SARS-CoV-2 infection, whereas vitamin C consumption decreased the infection odds during the third epidemic wave in Peru. Further research on the use of these medications is needed to establish a robust causal relationship with SARS-CoV-2 infection.

Open Access PDF

Concepts Keywords
Covid Adult
Future Aspirin
Medications Aspirin
Pandemic Case-Control Studies
Peruvian Commerce
COVID-19
Female
Humans
Male
Middle Aged
Peru
SARS-CoV-2
Young Adult

Semantics

Type Source Name
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease MESH emergency
drug DRUGBANK Acetylsalicylic acid
drug DRUGBANK Ascorbic acid
disease MESH infection
disease IDO history
disease IDO process
drug DRUGBANK L-Valine
disease MESH morbidity
disease IDO country
disease MESH infectious diseases
pathway REACTOME Reproduction
disease IDO blood
drug DRUGBANK Etoperidone
disease IDO nucleic acid
disease IDO pathogen
drug DRUGBANK Water
disease IDO assay
drug DRUGBANK Platinum
drug DRUGBANK Oxygen
drug DRUGBANK Dextrose unspecified form
drug DRUGBANK Ivermectin
drug DRUGBANK Chlorine Dioxide
drug DRUGBANK Acetaminophen
drug DRUGBANK Ibuprofen
drug DRUGBANK Azithromycin
drug DRUGBANK Clarithromycin
drug DRUGBANK Amoxicillin
drug DRUGBANK Ceftriaxone
drug DRUGBANK Ciprofloxacin
drug DRUGBANK Levofloxacin
drug DRUGBANK Enoxaparin
drug DRUGBANK Zinc
disease MESH hypertension
disease MESH obesity
disease IDO quality
disease MESH tics
disease MESH uncertainty
drug DRUGBANK Esomeprazole

Original Article

(Visited 4 times, 1 visits today)